How did you decide to participate in the Biomapas Academy?
When I used to walk past a pharmacy every day, I could never stop dreaming about being able to help people and develop innovative pharmaceuticals. So while studying biomedical sciences, I became interested in the drug development paths, which led me to medicinal chemistry. And one day at the university, I saw a poster about the Biomapas Academy, which could help me understand what, how, where, and when happens to pharmaceutical products during the whole journey to reach us, so I signed up for it without hesitation. Even though I am usually not a lucky person, I was selected to be one of the participants, which surprised me!
How was your experience regarding the Academy?
During the few months, I deepened my existing knowledge of drug development stages and expanded it to learn more about drug regulation and pharmacovigilance. After graduating from the Academy, I got the opportunity to try out regulatory affairs as part of Biomapas – I completed a summer internship in the Regulatory Affairs department.
How do you feel after graduating from the Academy?
I will never forget this practice in my life, not only because it fulfilled what I was looking for, but it let me realize that I want to return to this company after my graduation and put my accumulated knowledge to use. Thanks again to all Biomapas staff for their insights and advice, and I hope to see you soon.
Biomapas Academy
What is Clinical Research? Regulatory Affairs? Pharmacovigilance?
Adaptive Clinical Trials
What are Adaptive Clinical Trials? And how can we leverage their distinguished ability to evolve to improve clinical designs?
CSV & Risk Management in Pharmacovigilance
CSV & Risk Management Pharmacovigilance stands as a guardian in drug development and monitoring, ensuring that medicines remain safe and effective throughout their lifecycle. But behind this sentinel lies a complex web of systems, processes, and regulations, each...
Clinical Endpoints In Early Phase Oncology Trials
Clinical Endpoints In Early Phase Oncology Trials: Discover their influence on safety, study design, and regulatory compliance.
Discover how ICSR Pharmacovigilance safeguards drug safety for patients.
How individual case study reporting tracks adverse drug reactions and helps ensuring medication safety.
Case Study CSV
Learn how to go about Computerized Systems Validation for a cloud-based Safety Database in this Biomapas Case Study.
Choosing A Global Or Local CRO: A Comparative Analysis
Choosing a global or local cro? Learn what to consider when selecting a partner for global trials that require specialized, local expertise.
Rescue Study Strategies for Clinical Trials
How can a rescue study swiftly put your trial back on track? Learn all about rescue strategies and working with a rescue study CRO.
Expert Guidance on PSURs: Ensuring Drug Safety
Why are PSURs important? How do you write a PSUR? Find out all how PSURs and their role in guaranteeing patient safety.
Setting Up a Phase 1 Oncology Study
Explore setting up a Phase 1 Oncology Study successsfully! Learn about critical preparation, meticulous planning, and effective execution.
Safety Monitoring in Early Phase Oncology Trials: Key Points to Consider
For all clinical trials, it is crucial that the potential benefits of a medicinal product are determined, while monitoring any potential side effects. However, for early-phase oncology trials, the extensive monitoring of adverse events (AEs) is essential, considering...
